U.S. Markets closed
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • Dow 30

    35,677.02
    +73.94 (+0.21%)
     
  • Nasdaq

    15,090.20
    -125.50 (-0.82%)
     
  • Russell 2000

    2,291.27
    -4.91 (-0.21%)
     
  • Gold

    1,793.10
    +11.20 (+0.63%)
     
  • EUR/USD

    1.1650
    +0.0019 (+0.1631%)
     
  • 10-Yr Bond

    1.6550
    -0.0210 (-1.25%)
     
  • Vix

    15.43
    +0.42 (+2.80%)
     
  • GBP/USD

    1.3760
    -0.0036 (-0.2601%)
     
  • USD/JPY

    113.4800
    -0.5080 (-0.4457%)
     
  • BTC-USD

    60,653.73
    -2,589.35 (-4.09%)
     
  • CMC Crypto 200

    1,453.34
    -49.70 (-3.31%)
     
  • FTSE 100

    7,204.55
    +14.25 (+0.20%)
     
  • Nikkei 225

    28,804.85
    +96.25 (+0.34%)
     

Owens & Minor: Q2 Earnings Insights

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Owens & Minor (NYSE:OMI) increased 2.89% in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were up 100.00% year over year to $0.20, which beat the estimate of $0.19.

Revenue of $1,808,000,000 decreased by 27.21% from the same period last year, which missed the estimate of $1,920,000,000.

Looking Ahead

Earnings guidance hasn't been issued by the company for now.

Revenue guidance hasn't been issued by the company for now.

How To Listen To The Conference Call

Date: Aug 04, 2020

View more earnings on OMI

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/xh4wo6ms

Technicals

52-week high: $17.33

52-week low: $2.75

Price action over last quarter: Up 141.43%

Company Overview

Owens & Minor distributes consumable medical supplies to a variety of providers. The company operates in two segments that are Global products and Global Solutions. The company offers a portfolio of products and services to healthcare providers and manufacturers in the Global solutions segment. In the Global product segment, the company manufactures and sources medical-surgical products through our production and kitting operations. The majority of the revenue is generated from the Global solutions segment. The company operates in Asia, Europe, Latin America, and the United States, while the majority of revenue comes from the United States.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.